A detailed history of Great Lakes Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 5,085 shares of EW stock, worth $386,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,085
Previous 5,358 5.1%
Holding current value
$386,053
Previous $494,000 32.19%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$59.7 - $93.78 $16,298 - $25,601
-273 Reduced 5.1%
5,085 $335,000
Q2 2024

Aug 05, 2024

SELL
$84.3 - $94.31 $250,539 - $280,289
-2,972 Reduced 35.68%
5,358 $494,000
Q1 2024

May 08, 2024

SELL
$72.54 - $95.56 $422,182 - $556,159
-5,820 Reduced 41.13%
8,330 $796,000
Q4 2023

Feb 08, 2024

BUY
$61.71 - $77.76 $37,704 - $47,511
611 Added 4.51%
14,150 $1.08 Million
Q3 2023

Nov 07, 2023

SELL
$69.28 - $93.38 $1.84 Million - $2.48 Million
-26,600 Reduced 66.27%
13,539 $937,000
Q2 2023

Aug 10, 2023

BUY
$81.41 - $94.33 $597,630 - $692,476
7,341 Added 22.38%
40,139 $3.79 Million
Q1 2023

May 10, 2023

SELL
$74.26 - $84.51 $102,553 - $116,708
-1,381 Reduced 4.04%
32,798 $2.71 Million
Q4 2022

Feb 09, 2023

SELL
$68.3 - $87.44 $19,328 - $24,745
-283 Reduced 0.82%
34,179 $2.55 Million
Q3 2022

Nov 09, 2022

SELL
$82.37 - $107.29 $339,776 - $442,571
-4,125 Reduced 10.69%
34,462 $2.85 Million
Q2 2022

Aug 09, 2022

SELL
$86.5 - $128.27 $261,143 - $387,247
-3,019 Reduced 7.26%
38,587 $3.67 Million
Q1 2022

May 06, 2022

SELL
$101.96 - $128.34 $262,139 - $329,962
-2,571 Reduced 5.82%
41,606 $4.9 Million
Q4 2021

Feb 09, 2022

SELL
$106.37 - $130.68 $5.06 Million - $6.22 Million
-47,604 Reduced 51.87%
44,177 $5.72 Million
Q3 2021

Nov 09, 2021

BUY
$102.91 - $122.75 $2.83 Million - $3.37 Million
27,494 Added 42.77%
91,781 $10.4 Million
Q2 2021

Aug 11, 2021

BUY
$83.84 - $104.76 $1.85 Million - $2.31 Million
22,064 Added 52.26%
64,287 $6.66 Million
Q1 2021

May 03, 2021

SELL
$78.68 - $90.67 $110,545 - $127,391
-1,405 Reduced 3.22%
42,223 $3.53 Million
Q4 2020

Feb 09, 2021

BUY
$71.69 - $91.23 $124,668 - $158,648
1,739 Added 4.15%
43,628 $3.98 Million
Q3 2020

Nov 04, 2020

SELL
$67.19 - $87.44 $51,736 - $67,328
-770 Reduced 1.81%
41,889 $3.34 Million
Q2 2020

Aug 07, 2020

BUY
$57.54 - $76.95 $1.66 Million - $2.22 Million
28,892 Added 209.86%
42,659 $2.95 Million
Q1 2020

May 08, 2020

BUY
$52.41 - $81.0 $79,768 - $123,282
1,522 Added 12.43%
13,767 $2.6 Million
Q4 2019

Feb 07, 2020

SELL
$71.7 - $82.09 $108,123 - $123,791
-1,508 Reduced 10.96%
12,245 $2.86 Million
Q3 2019

Nov 06, 2019

BUY
$61.55 - $75.43 $23,819 - $29,191
387 Added 2.9%
13,753 $3.02 Million
Q2 2019

Aug 05, 2019

SELL
$55.74 - $64.41 $16,164 - $18,678
-290 Reduced 2.12%
13,366 $2.47 Million
Q1 2019

May 07, 2019

SELL
$47.89 - $64.05 $127,531 - $170,565
-2,663 Reduced 16.32%
13,656 $2.61 Million
Q4 2018

Feb 13, 2019

SELL
$46.41 - $56.94 $979,715 - $1.2 Million
-21,110 Reduced 56.4%
16,319 $2.5 Million
Q3 2018

Nov 30, 2018

BUY
$45.7 - $58.03 $1.63 Million - $2.08 Million
35,769 Added 2154.76%
37,429 $6.52 Million
Q3 2018

Nov 15, 2018

SELL
$45.7 - $58.03 $1.91 Million - $2.42 Million
-41,769 Reduced 96.18%
1,660 $289,000
Q2 2018

Aug 13, 2018

BUY
$42.45 - $51.3 $623,505 - $753,494
14,688 Added 51.1%
43,429 $6.32 Million
Q1 2018

May 07, 2018

BUY
$37.19 - $47.45 $463,945 - $591,938
12,475 Added 76.69%
28,741 $4.01 Million
Q4 2017

Feb 08, 2018

SELL
$33.79 - $39.39 $155,197 - $180,918
-4,593 Reduced 22.02%
16,266 $1.83 Million
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $756,973 - $809,954
20,859
20,859 $2.28 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.